The Global Perspective on Value in Cancer Care
Elisabeth De Vries and Richard Sullivan
On June 1, 2014, the penultimate day of the 50th Annual Meeting of the American Society of Clini- cal Oncology (ASCO), the discussion on value in cancer care was rekindled, but this time on a global scale. The session, “ASCO/European Cancer Organisation (ECCO) Joint Session: Value and Cancer Care,” saw participation from physicians and economists from around the world, with individual perspectives on defining value and the programs being developed to address the issue. Regulatory approval does not guarantee patient access to efficient therapies. So where lies the problem?